Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ELETRIPTAN HYDROBROMIDE vs ELIGLUSTAT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ELETRIPTAN HYDROBROMIDE vs ELIGLUSTAT: Safety Overview

Metric ELETRIPTAN HYDROBROMIDE ELIGLUSTAT
Total FAERS Reports 2,158 1,368
Deaths Reported 12 18
Death Rate 0.6% 1.3%
Hospitalizations 271 173
Average Patient Age 52.6 yrs 48.6 yrs
% Female Patients 86.2% 57.1%
FDA Approval Date Aug 11, 2017 Aug 17, 2022
Manufacturer Zydus Pharmaceuticals USA Inc. Genzyme Corporation
Route ORAL ORAL
Marketing Status Prescription Prescription